Skip to main content

Table 6 Comparison of outcome measurements between patients who received Dangguixu-san and those who received placebo for grade II acute lateral ankle sprain(n = 23)

From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial

Dependent variables

Group (n)

Week 0 (M ± SD)

Week 1 (M ± SD)

Week 5 (M ± SD)

Difference (w1–w0)

Z (p)a

Difference (w5–w0)

Z (p)a

Difference (w5–w1)

Z (p)a

VAS of pain

DS (n = 11)

50.91 ± 18.14

30.91 ± 22.56

8.45 ± 5.65

−20.00 ± 27.93

− 0.71 (0.479)

− 42.45 ± 18.38

− 1.54 (0.123)

− 22.45 ± 19.54

− 3.03 (0.002)

Placebo (n = 12)

44.17 ± 11.65

16.00 ± 15.47

15.00 ± 15.08

− 28.17 ± 9.93

−29.17 ± 13.11

−1.00 ± 11.65

Degree of edema

DS (n = 11)

1.36 ± 1.03

0.27 ± 0.47

0.36 ± 0.50

− 0.95 ± 1.10

− 1.31 (0.189)

− 0.98 ± 0.83

− 0.85 (0.396)

0.03 ± 0.51

− 0.72 (0.473)

Placebo (n = 12)

1.08 ± 0.79

0.50 ± 0.67

0.25 ± 0.62

− 0.41 ± 0.67

− 0.68 ± 0.86

−0.28 ± 0.81

TOTAL

EQ-5D-5L

DS (n = 11)

11.73 ± 3.72

9.73 ± 3.35

5.82 ± 0.75

− 2.00 ± 3.49

− 0.88 (0.880)

− 5.91 ± 3.59

− 1.85 (0.065)

− 3.91 ± 2.88

− 2.66 (0.008)

Placebo (n = 12)

9.67 ± 2.31

7.50 ± 2.15

6.17 ± 1.40

− 2.17 ± 1.40

− 3.50 ± 1.68

−1.33 ± 1.61

TOTAL

FAOS

DS (n = 11)

261.77 ± 79.97

341.45 ± 88.16

459.39 ± 40.28

79.67 ± 88.48

− 0.31 (0.758)

197.62 ± 71.97

− 1.23 (0.218)

117.95 ± 62.34

− 2.59 (0.010)

Placebo (n = 12)

286.15 ± 64.35

389.86 ± 72.46

443.85 ± 52.68

103.71 ± 60.16

157.70 ± 49.73

53.99 ± 46.46

FAOS

ache

DS (n = 11)

52.00 ± 15.63

69.69 ± 14.41

95.19 ± 5.28

17.68 ± 14.67

− 1.05 (0.294)

43.18 ± 14.36

− 2.35 (0.019)

25.50 ± 11.79

− 3.49 (< 0.001)

Placebo (n = 12)

59.67 ± 11.50

82.63 ± 16.29

89.35 ± 10.51

22.92 ± 14.08

29.64 ± 9.29

6.73 ± 8.16

  1. aMann-Whitney U test